Kufstein, Austria

Alexander Backes

This inventor holds 1 USPTO granted patent. Top assignee: Forma Therapeutics, Inc.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander Backes. Retrieved from https://idiyas.com/inventor/alexander-backes-eglguuo8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Alexander Backes

Introduction

Alexander Backes is a notable inventor based in Kufstein, Austria. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer treatment. His work is characterized by a focus on innovative solutions that address critical health challenges.

Latest Patents

One of Alexander Backes' key patents is related to Raf inhibitors. The present invention provides derivatives of pyrido[2,3-d]pyrimidin-7-one. These compounds serve as inhibitors of kinases such as Raf, demonstrating anti-proliferative activity against tumor cells. This innovation is particularly useful in the treatment of diseases, including cancer.

Career Highlights

Alexander Backes is currently associated with Forma Therapeutics, Inc., where he continues to advance his research and development efforts. His work at this company underscores his commitment to creating impactful medical solutions.

Collaborations

Throughout his career, Alexander has collaborated with esteemed colleagues, including Andreas Schoop and Joachim Vogt. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

In summary, Alexander Backes is a dedicated inventor whose work in developing Raf inhibitors showcases his commitment to advancing cancer treatment. His contributions to the field are invaluable and reflect a deep understanding of the complexities of medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…